Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge, M Martin… - Annals of oncology, 2001 - Elsevier
Background To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A)
combination therapy in women with advanced breast cancer. To define a dose range of A for …
被引用次数：107 相关文章

[引用][C] Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge, M Martin… - Annals of …, 2001 - cir.nii.ac.jp
Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of
657 women with advanced breast cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge… - Annals of …, 2001 - annalsofoncology.org
Background To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A)
combination therapy in women with advanced breast cancer. To define a dose range of A for …

Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky… - Annals of oncology …, 2001 - pubmed.ncbi.nlm.nih.gov
Background To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A)
combination therapy in women with advanced breast cancer. To define a dose range of A for …

Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer.

L Gianni, P Dombernowsky, G Sledge… - Annals of Oncology …, 2001 - europepmc.org
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of
657 women with advanced breast cancer. - Abstract - Europe PMC Sign in | Create an …

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge, M Martin… - Annals of …, 2001 - elibrary.ru
Background: To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A)
combination therapy in women with advanced breast cancer. To define a dose range of A for …

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge, M Martin… - Annals of …, 2001 - infona.pl
Background: To determine the cardiotoxicity of paclitaxel (T) plusdoxorubicin (A)
combination therapy in women with advanced breast cancer. Todefine a dose range of A for …
[PDF] researchgate.net

[PDF][PDF] Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L Gianni, P Dombernowsky, G Sledge… - Annals of …, 2001 - researchgate.net
Background: To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A)
combination therapy in women with advanced breast cancer. To define a dose range of A for …

[引用][C] Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

L GIANNI, P DOMBERNOWSKY, C WEIL… - Annals of …, 2001 - pascal-francis.inist.fr
Cardiac function following combination therapy with paclitaxel and doxorubicin : An
analysis of 657 women with advanced breast cancer CNRS Inist Pascal-Francis CNRS …

[引用][C] Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer

L GIANNI - Ann Oncol., 2001 - cir.nii.ac.jp
Cardiac function following combination therapy with paclitaxel and doxorubicin : an analysis
of 657 women with advanced breast cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …